Tuesday, October 22, 2013

Thor: The Dark World: Film Review


Nobody gives good sneer like Tom Hiddleston, back once again in the pleather leggings and goat-horned helmet to play bad guy Loki in Thor: The Dark World and pretty much steal the whole show. Amiable hunk Chris Hemsworth may play the title character in this subset of Marvel's meta-Avengers franchise, but this well-intentioned "witless oaf," as his evil foster brother describes him at one point, is practically a guest at his own party here, as scads of new characters and millions of dollars worth of CGI crowd the screen. Most of it pales into insignificance when Loki takes the stage, which isn't often enough given how wildly uneven the sections without him are. Although director Alan Taylor manages to get things going properly for the final battle in London, the long stretches before that on Asgard and the other branches of Yggdrasil are a drag, like filler episodes of Game of Thrones but without the narrative complexity, mythical heft or all-pervading sexiness.



PHOTOS: Exclusive Portraits of Chris Hemsworth



In a year when so many box-office sure bets, especially sequels, have been a bust, it's harder than usual to predict how well Thor: The Dark World will do. Tracking numbers are predicting an opening weekend somewhere in the $75 million stratosphere. Meh word of mouth could diminish returns over the subsequent weeks, but who knows. There are a lot of die-hard fans out there, especially for the Marvel-verse, but then again they can also be a very discerning and exacting audience.


The opening sequence provides backstory on the Dark Elves, sharp-beaked, pointy-eared meanies from Alfheim who date back to before the beginning of time and claim a black, gaseous substance called Aether as their all-powerful weapon of mass destruction. They're seen being vanquished (but, of course, not quite) by Thor's grandfather. Thereafter, the story basically picks up where The Avengers left off, with Loki in manacles back on Thor's home planet -- or "realm," they call it -- Asgard, after trying to take over our world and trashing New York in the process. His glass-walled, whited-out cell in the dungeon bears a striking resemblance to similar baddie-holding pens in films past, from the X-Men franchise to Skyfall; there he reads books and has heart-to-black-heart chats with his adopted mother, Frigga (Rene Russo, finally getting more to do in this installment than just standing around smiling).


In uppity other realms, Thor has been putting down insurgents alongside his warrior buddies -- the Lady Sif (Jaimie Alexander), and the "Warriors Three," Volstagg (Ray Stevenson), Hogun (Tadanobu Asano) and Fandral (Zachary Levi, stepping in for Josh Dallas) -- and preparing to take over from dad Odin (Anthony Hopkins) as king. Since the Bifrost bridge that connects Asgard to Earth was destroyed two films back, Thor has no means to travel to our world to see Jane Foster (Natalie Portman), the fetching lady scientist he became smitten with in the first movie but barely mentioned in The Avengers.


Luckily, omnipotent bridge-keeper Heimdall (Idris Elba) can see she's basically fine, albeit mightily annoyed with Thor for not staying in touch. Based in London now, she's trying to heal her wounded pride by having a blind date with nice but decidedly non-godly Richard (Chris O'Dowd, criminally underused). She dumps him unceremoniously as soon as her intern Darcy (Kat Dennings), who now has her own intern (Jonathan Howard), interrupts their meal with evidence of a space-fabric disturbance that seems familiar. While investigating the weird phenomenon, Darcy is sucked into another realm and infected with Aether, which sometimes give her scary white-free eyes, evoking happy memories of Black Swan.


PHOTOS: Behind the Scenes of 'Thor'


It turns out that The Convergence, the incredibly rare astronomical alignment of all nine realms, is beginning, hence the possibility of Bifrost-free travel between Earth and Asgard. Thor comes to collect Jane, gets slapped a few times for not calling her, and they commute back to Asgard to see its intricate landscape of cavernous assembly halls and gleaming golden towers, fashioned in the forge of many a mainframe, all impressively conceived and executed by production designer Charles Wood and visual effects supervisor Jake Morrison. That said, some of the more barren landscapes look decidedly less convincing with their papier-mache boulders and screen-like backdrops when Malekith (Christopher Eccleston), the leader of the surviving Dark Elves and his crew, come to try and collect their Aether.


The middle section is mostly a muddle, with endless cross-cutting between the Dark Elves plotting, attacking and then retreating to plot some more, earthlings Darcy and Dr. Erik Selvig (Stellan Skarsgard) worrying, and the Asgardians bickering over what they should do. The latter finally decide -- despite manifest evidence provided by two previous films that it would be a very bad idea -- to release Loki from jail so that he can fight on their side. Once Loki is back in play, magisterially sneering and loftily dispensing one-liners, the whole thing perks up again. Until, that is, he's off the scene again for reasons which can't be revealed.


The final showdown in Greenwich, London, squares off the Dark Elves and their unleashed Aether against the Asgardians and humans, managing in the process to grind most of Sir Christopher Wren's exquisite 17th century Royal Naval College buildings into a fine, powdery digitally rendered pixel dust. It's here, in this stretch, that the film finally gets its mojo back, finding the requisite balance between bombast and wise-cracks that made the first Thor work in its finest moments. Admittedly, nothing Loki-unrelated in Thor: The Dark World quite matches the hilarity of the scene in the first film where Thor strides into a pet shop and demands a horse, but the finale pleasingly gives the hardworking supports a chance to josh around, the stereoscopy comes into its own, and the editing, credited to Dan Lebental and Wyatt Smith, finds its groove. What a shame the script up until this point is too often so ramshackle and plodding, like the writers were finishing off the dialogue in between catering breaks.


With a project so firmly supervised by its studio, it's hard to tell how much director Alan Taylor should be credited or blamed for the finished result. The Dark World is certainly a far cry from the jaunty little indie crime caper Palookaville (1995) he started his career with. Since then, he's directed some great episodes on some of the very best TV series, including The Sopranos, Mad Men, and, most germane of all in this context, Game of Thrones, on which he also serves as a co-executive producer. Perhaps it's unfair to compare Thrones with The Dark World given the former has so much more scope to build its world over hours of programming, but for all the budget spent on lavish visual effects in The Dark World nothing in it quite compares to the White Walkers marching relentlessly through the snowy Northern wastes at the end of the Taylor-directed episode "Valar Morghulis."


Viewers are advised to not make for the exit as soon as the end credits start rolling and stick it out until the very end if they want to see a postscript that reveals a character who may prove central to the next film. Indeed, the end credits have two Easter-egg scenes, in keeping with the trickle of in-jokes aimed at Marvel aficionados that provides a flash-quick cameo for one of Thor's superhero companions from The Avengers.


Production: Marvel Studios
Cast: Chris Hemsworth, Natalie Portman, Tom Hiddleston, Stellan Skarsgard, Idris Elba, Christopher Eccleston, Anthony Hopkins, Rene Russo, Kat Dennings
Director: Alan Taylor
Screenwriter: Christopher L. Yost, Christopher Markus & Stephen McFeely, based on a story by Don Payne and Robert Rodat
Producers: Kevin Feige
Executive producers: Nigel Gostelow, Stan Lee, Victoria Alonso, Craig Kyle, Alan Fine, Louis D'Esposito
Director of photography: Kramer Morgenthau
Production designer: Charles Wood
Costume designer: Wendy Partridge
Editors: Dan Lebental, Wyatt Smith
Music: Brian Taylor


Not yet rated, 112 minutes


Source: http://feedproxy.google.com/~r/thr/news/~3/nz9x_p1ZQ2o/649886
Tags: Cleveland Indians   Rihanna Pour It Up Video   broncos   American flag   twerk  

Wall Street up on Fed-affirming jobs data; Netflix hit


By Julia Edwards

NEW YORK (Reuters) - U.S. stocks climbed on Tuesday, pushing the S&P 500 to a new intraday record, after weaker-than-expected job creation last month validated expectations the Federal Reserve will maintain its economic stimulus into next year.

The Nasdaq pared gains after some of the year's biggest winners, including Netflix Inc , reversed course to move lower.

"The most volatile sector, in terms of risk and return, is going to be the technology sector," said Jon Smith, chief investment officer at DT Investment Partners. "You can never necessarily tell exactly what is going to happen in the tech story in general."

U.S. employers added 148,000 workers last month, well below the 180,000 economists had expected. The data is seen as supporting the Fed's decision to maintain its $85 billion in monthly bond purchases, which has helped stocks rally in 2013.

Many economists think the Fed will hold off on scaling back its easy money policy, which has kept borrowing costs low, until next year.

"The jobs report gave us a Goldilocks number. It was kind of warm, but wasn't too hot or too cold either. It was right there, in line to push back tapering to next year," said Ryan Detrick, senior technical strategist at Schaeffer's Investment Research.

Netflix shares fell 6.4 percent to $332.90, reversing the rise that followed the release of the company's earnings report on Monday. Volume in the stock spiked as it fell into negative territory on the day. With more than 17 million shares traded, volume was nearly six times the average over the last 50 days.

Apple lost 0.4 percent to $519.23, though losses ebbed after the company unveiled a new line of iPads at 1 p.m. EST (1700 GMT).

The Dow Jones industrial average <.dji> was up 49.96 points, or 0.32 percent, at 15,442.16. The Standard & Poor's 500 Index <.spx> was up 7.34 points, or 0.42 percent, at 1,752.00. The Nasdaq Composite Index <.ixic> was up 2.02 points, or 0.05 percent, at 3,922.07.

The S&P earlier hit a record intraday high at 1,759.33.

Payroll figures for August were revised higher and the September unemployment rate ticked down to 7.2 percent from 7.3 percent.

Transocean shares rose 5.6 percent to $49.18 after S&P Dow Jones Indices announced the drilling services company will replace Dell on the S&P 500 index after the close of trading next Monday.

Shares of cloud software maker VMware Inc rose 5 percent to $86.79 a day after it reported a higher-than-expected quarterly profit.

High-end handbag maker Coach fell 7.4 percent to $50.17 after it posted smaller-than-expected quarterly revenue.

(Reporting by Julia Edwards, additional reporting by Rodrigo Campos and Ellen Freilich; Editing by Chizu Nomiyama, Kenneth Barry and Nick Zieminski)

Source: http://news.yahoo.com/stock-futures-flat-ahead-payrolls-netflix-jumps-113650678--sector.html
Similar Articles: New 100 Dollar Bill   Scott Eastwood   iOS 7 download   seattle seahawks   The White Queen  

Coffee consumption reduces risk of liver cancer

Coffee consumption reduces risk of liver cancer


[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:

22-Oct-2013



[


| E-mail

]


Share Share

Contact: Aimee Frank
media@gastro.org
301-941-2620
American Gastroenterological Association





Bethesda, MD (Oct. 22, 2013) -- Coffee consumption reduces risk of hepatocellular carcinoma (HCC), the most common type of liver cancer, by about 40 percent, according to an up-to-date meta-analysis published in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. Further, some data indicate that three cups of coffee per day reduce liver cancer risk by more than 50 percent.


"Our research confirms past claims that coffee is good for your health, and particularly the liver," said Carlo La Vecchia, MD, study author from the department of epidemiology, Istituto di Ricerche Farmacologiche "Mario Negri," and department of clinical sciences and community health, Universit degli Studi di Milan, Italy. "The favorable effect of coffee on liver cancer might be mediated by coffee's proven prevention of diabetes, a known risk factor for the disease, or for its beneficial effects on cirrhosis and liver enzymes."


Researchers performed a meta-analysis of articles published from 1996 through September 2012, ultimately studying 16 high-quality studies and a total of 3,153 cases. This research fills an important gap as the last meta-analysis was published in 2007, and since then there has been data published on more than 900 cases of HCC.


Despite the consistency of results across studies, time periods and populations, it is difficult to establish whether the association between coffee drinking and HCC is causal, or if this relationship may be partially attributable to the fact that patients with liver and digestive diseases often voluntarily reduce their coffee intake.


"It remains unclear whether coffee drinking has an additional role in liver cancer prevention," added Dr. La Vecchia. "But, in any case, such a role would be limited as compared to what is achievable through the current measures."


Primary liver cancers are largely avoidable through hepatitis B virus vaccination, control of hepatitis C virus transmission and reduction of alcohol drinking. These three measures can, in principle, avoid more than 90 percent of primary liver cancer worldwide.


Liver cancer is the sixth most common cancer in the world, and the third most common cause of cancer death. HCC is the main type of liver cancer, accounting for more than 90 percent of cases worldwide. Chronic infections with hepatitis B and C viruses are the main causes of liver cancer; other relevant risk factors include alcohol, tobacco, obesity and diabetes.


###


Learn more about liver cancer in AGA's patient brochure, "Understanding Cirrhosis of the Liver".


About the AGA Institute


The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. http://www.gastro.org.


About Clinical Gastroenterology and Hepatology


The mission of Clinical Gastroenterology and Hepatology is to provide readers with a broad spectrum of themes in clinical gastroenterology and hepatology. This monthly peer-reviewed journal includes original articles as well as scholarly reviews, with the goal that all articles published will be immediately relevant to the practice of gastroenterology and hepatology. For more information, visit http://www.cghjournal.org.


Like AGA and Clinical Gastroenterology and Hepatology on Facebook.


Join AGA on LinkedIn.


Follow us on Twitter @AmerGastroAssn.
Check out our videos on YouTube.


[ Back to EurekAlert! ]

[


| E-mail


Share Share

]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.




Coffee consumption reduces risk of liver cancer


[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:

22-Oct-2013



[


| E-mail

]


Share Share

Contact: Aimee Frank
media@gastro.org
301-941-2620
American Gastroenterological Association





Bethesda, MD (Oct. 22, 2013) -- Coffee consumption reduces risk of hepatocellular carcinoma (HCC), the most common type of liver cancer, by about 40 percent, according to an up-to-date meta-analysis published in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. Further, some data indicate that three cups of coffee per day reduce liver cancer risk by more than 50 percent.


"Our research confirms past claims that coffee is good for your health, and particularly the liver," said Carlo La Vecchia, MD, study author from the department of epidemiology, Istituto di Ricerche Farmacologiche "Mario Negri," and department of clinical sciences and community health, Universit degli Studi di Milan, Italy. "The favorable effect of coffee on liver cancer might be mediated by coffee's proven prevention of diabetes, a known risk factor for the disease, or for its beneficial effects on cirrhosis and liver enzymes."


Researchers performed a meta-analysis of articles published from 1996 through September 2012, ultimately studying 16 high-quality studies and a total of 3,153 cases. This research fills an important gap as the last meta-analysis was published in 2007, and since then there has been data published on more than 900 cases of HCC.


Despite the consistency of results across studies, time periods and populations, it is difficult to establish whether the association between coffee drinking and HCC is causal, or if this relationship may be partially attributable to the fact that patients with liver and digestive diseases often voluntarily reduce their coffee intake.


"It remains unclear whether coffee drinking has an additional role in liver cancer prevention," added Dr. La Vecchia. "But, in any case, such a role would be limited as compared to what is achievable through the current measures."


Primary liver cancers are largely avoidable through hepatitis B virus vaccination, control of hepatitis C virus transmission and reduction of alcohol drinking. These three measures can, in principle, avoid more than 90 percent of primary liver cancer worldwide.


Liver cancer is the sixth most common cancer in the world, and the third most common cause of cancer death. HCC is the main type of liver cancer, accounting for more than 90 percent of cases worldwide. Chronic infections with hepatitis B and C viruses are the main causes of liver cancer; other relevant risk factors include alcohol, tobacco, obesity and diabetes.


###


Learn more about liver cancer in AGA's patient brochure, "Understanding Cirrhosis of the Liver".


About the AGA Institute


The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. http://www.gastro.org.


About Clinical Gastroenterology and Hepatology


The mission of Clinical Gastroenterology and Hepatology is to provide readers with a broad spectrum of themes in clinical gastroenterology and hepatology. This monthly peer-reviewed journal includes original articles as well as scholarly reviews, with the goal that all articles published will be immediately relevant to the practice of gastroenterology and hepatology. For more information, visit http://www.cghjournal.org.


Like AGA and Clinical Gastroenterology and Hepatology on Facebook.


Join AGA on LinkedIn.


Follow us on Twitter @AmerGastroAssn.
Check out our videos on YouTube.


[ Back to EurekAlert! ]

[


| E-mail


Share Share

]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.




Source: http://www.eurekalert.org/pub_releases/2013-10/aga-ccr102213.php
Similar Articles: Million Second Quiz   Galaxy Note 3   indicted   paulina gretzky   brian wilson  

A fresh solution for the lindane problem

A fresh solution for the lindane problem


[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:

22-Oct-2013



[


| E-mail

]


Share Share

Contact: Aitziber Lasa
a.lasa@elhuyar.com
34-943-363-040
Elhuyar Fundazioa



The UPV/EHU-University of the Basque Country and Tecnalia are seeking fresh solutions by means of iron nanoparticles to eliminate the consequences of lindane manufacture and use.




For many years two companies located in Bizkaia, Bilbao Chemicals (Barakaldo 1947-1987) and Nexana (Erandio 1952-1982), had been manufacturing lindane and dumping it into the environment with no control whatsoever. Today we have become aware of the need to solve the problems caused by this dumping and the difficulty in achieving this since there is no viable process that will safely destroy the lindane mixed with the soil. A study by the UPV/EHU's Department of Physical Chemistry and Analytical Chemistry in collaboration with Tecnalia has confirmed the hypothesis of the high reactive capacity of iron nanoparticles to degrade lindane. The study has been published in the prestigious journal Chemosphere.


Lindane has been routinely used among farmers as an insecticide and pesticide, and although its use has now been banned, the consequences of lindane manufacture and use have not disappeared. The risk posed by lindane lies in the fact that it is not only toxic, it can be accumulated in living organisms. From an environmental point of view, it has low solubility, high stability and high persistence and resistance to degradation in the environment.


Although there is as yet no viable process for safely destroying lindane, an innovative, efficient alternative is to use iron nanoparticles. Iron nanoparticles have shown themselves to be very effective as a decontaminating agent when it comes to handling various families of highly toxic compounds like lindane. However, they have a number of drawbacks that limit and hamper their application, since they oxidize easily in the presence of air and their tendency to agglomerate limits their mobility in the medium in which one is seeking to apply them. So the need to protect them is done by using Carboxymethyl cellulose (CMC), polyaspartate (PAP) and poly (acrylic acid) (PAA) as biodegradable polymer coatings.


From the laboratory to the land


"The main aim of our study was to validate on a laboratory scale whether these iron nanoparticles can be applied and whether they have the capacity to eliminate the lindane," explained Itxaso San Romn, member of the UPV/EHU's Department of Analytical Chemistry. This requires advanced analytical techniques capable of monitoring the degradation process, which will take place in the presence of the various nanoparticles, determining the speed of the reaction and likewise detecting the possible by-products that are formed in the course of that reaction.


The process to degrade the contaminant itself was evaluated by analysing samples of water containing lindane using the technique called solid-phase extraction (SPE). That way the lindane remaining in the solution was measured over time. Likewise, the technique involving solid-phase microextraction (SPME) was used to detect the gas by-products generated during the degradation at each moment in the study by means of gas chromatography with a mass spectrometry (GC-MS) detector.


Through the techniques employed it was possible to compare and study the effectiveness of the various types of nanoparticles used to degrade the lindane and to find out the reaction speed in each case. The study showed how the lindane gradually disappeared in the presence of the nanoparticles over time (between 1 and 72 hours), revealing various reaction tendencies and speeds. "The protection of the nanoparticles increases the effectiveness of the degradation of the lindane and also prevents the agglomeration of the nanoparticles; the result is a greater reaction surface," pointed out Itxaso San Romn. However, "as the lindane concentration in water diminished over time, other less harmful by-products were seen to appear; as time passes these will probably be transformed into more innocuous compounds," she said. That way "both the coated and uncoated nanoparticles have been shown to be capable of transforming the lindane into other less harmful products," stressed San Romn. "This fact provides valuable information for applying them in the future as a decontaminating tool in real environmental matrices," she added.


###


About the author:


Itxaso San Romn is a researcher at the UPV/EHU's Department of Analytical Chemistry. The research referred to was conducted in collaboration with the UPV/EHU's Department of Physical Chemistry and the Tecnalia Corporation.



[ Back to EurekAlert! ]

[


| E-mail


Share Share

]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.




A fresh solution for the lindane problem


[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:

22-Oct-2013



[


| E-mail

]


Share Share

Contact: Aitziber Lasa
a.lasa@elhuyar.com
34-943-363-040
Elhuyar Fundazioa



The UPV/EHU-University of the Basque Country and Tecnalia are seeking fresh solutions by means of iron nanoparticles to eliminate the consequences of lindane manufacture and use.




For many years two companies located in Bizkaia, Bilbao Chemicals (Barakaldo 1947-1987) and Nexana (Erandio 1952-1982), had been manufacturing lindane and dumping it into the environment with no control whatsoever. Today we have become aware of the need to solve the problems caused by this dumping and the difficulty in achieving this since there is no viable process that will safely destroy the lindane mixed with the soil. A study by the UPV/EHU's Department of Physical Chemistry and Analytical Chemistry in collaboration with Tecnalia has confirmed the hypothesis of the high reactive capacity of iron nanoparticles to degrade lindane. The study has been published in the prestigious journal Chemosphere.


Lindane has been routinely used among farmers as an insecticide and pesticide, and although its use has now been banned, the consequences of lindane manufacture and use have not disappeared. The risk posed by lindane lies in the fact that it is not only toxic, it can be accumulated in living organisms. From an environmental point of view, it has low solubility, high stability and high persistence and resistance to degradation in the environment.


Although there is as yet no viable process for safely destroying lindane, an innovative, efficient alternative is to use iron nanoparticles. Iron nanoparticles have shown themselves to be very effective as a decontaminating agent when it comes to handling various families of highly toxic compounds like lindane. However, they have a number of drawbacks that limit and hamper their application, since they oxidize easily in the presence of air and their tendency to agglomerate limits their mobility in the medium in which one is seeking to apply them. So the need to protect them is done by using Carboxymethyl cellulose (CMC), polyaspartate (PAP) and poly (acrylic acid) (PAA) as biodegradable polymer coatings.


From the laboratory to the land


"The main aim of our study was to validate on a laboratory scale whether these iron nanoparticles can be applied and whether they have the capacity to eliminate the lindane," explained Itxaso San Romn, member of the UPV/EHU's Department of Analytical Chemistry. This requires advanced analytical techniques capable of monitoring the degradation process, which will take place in the presence of the various nanoparticles, determining the speed of the reaction and likewise detecting the possible by-products that are formed in the course of that reaction.


The process to degrade the contaminant itself was evaluated by analysing samples of water containing lindane using the technique called solid-phase extraction (SPE). That way the lindane remaining in the solution was measured over time. Likewise, the technique involving solid-phase microextraction (SPME) was used to detect the gas by-products generated during the degradation at each moment in the study by means of gas chromatography with a mass spectrometry (GC-MS) detector.


Through the techniques employed it was possible to compare and study the effectiveness of the various types of nanoparticles used to degrade the lindane and to find out the reaction speed in each case. The study showed how the lindane gradually disappeared in the presence of the nanoparticles over time (between 1 and 72 hours), revealing various reaction tendencies and speeds. "The protection of the nanoparticles increases the effectiveness of the degradation of the lindane and also prevents the agglomeration of the nanoparticles; the result is a greater reaction surface," pointed out Itxaso San Romn. However, "as the lindane concentration in water diminished over time, other less harmful by-products were seen to appear; as time passes these will probably be transformed into more innocuous compounds," she said. That way "both the coated and uncoated nanoparticles have been shown to be capable of transforming the lindane into other less harmful products," stressed San Romn. "This fact provides valuable information for applying them in the future as a decontaminating tool in real environmental matrices," she added.


###


About the author:


Itxaso San Romn is a researcher at the UPV/EHU's Department of Analytical Chemistry. The research referred to was conducted in collaboration with the UPV/EHU's Department of Physical Chemistry and the Tecnalia Corporation.



[ Back to EurekAlert! ]

[


| E-mail


Share Share

]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.




Source: http://www.eurekalert.org/pub_releases/2013-10/ef-afs102213.php
Tags: melissa mccarthy   michigan football   Alice Munro   Paula Patton   Eiza Gonzalez  

Microsoft repackages websites as Windows Phone apps in bid to lure developers


Microsoft repackages websites as Windows Phone apps in bid to lure developers


What do you do when your conventional strategies for attracting mobile app developers haven't always been successful? If you're Microsoft, you build web apps. The company tells ZDNet that it has been repackaging dozens of popular websites as Windows Phone apps in an attempt to get the site owners to write native software. While clever, the approach is definitely a gamble. Microsoft notes that it doesn't own any of the content in these web apps -- and it's not clear whether the site operators are aware of Redmond's activities here. We've reached out to the company for more details and will update this post as we learn more.


Source: http://www.engadget.com/2013/10/21/microsoft-repackages-websites-as-windows-phone-apps/?ncid=rss_truncated
Related Topics: breast cancer awareness   North West   big brother spoilers   bradley manning   princess diana  

Allison wants Ferrari improvement before end of year | 2013 Indian Grand Prix


James Allison, Fernando Alonso, Ferrari, Monza, 2013New Ferrari technical director James Allison has targeted an improved performance from the team over the final four races.


“The Korean and Japanese Grands Prix were both disappointing for us as our car was not right at the front or winning, which is not the level we should be at,” said Allison, who joined Ferrari from Lotus earlier this year.


“However, the team performed very well at the track with a group that is strategically very astute and we have drivers who can bring the car home in good positions. But those results are not what we are aiming for, so we need to improve for the remaining races.”


Allison is returning to Ferrari after nine years at Renault and Lotus. He said: “There’s excitement but also a lot of nostalgia as this is a team with whom I share many happy memories of all the victories from 2000 to 2004.”


“So nostalgia, excitement and pleasure at seeing so many faces I remember from before, who were junior members in the team when I was here the last time, but have now grown up with the team and hold senior positions.


“But most of all I have a feeling of determination to play my part alongside everyone else, in returning to victory with this team.”


Allison added there have been “many changes within the Scuderia” while he was away.


“The team is bigger and more complex, but its character, its emotion is very similar and recognisable the moment you walk through the door. You can also feel the hunger to win again.”


2013 Indian Grand Prix


Browse all 2013 Indian Grand Prix articles[1]

Image © Ferrari/Ercole Colombo



References

  1. ^ Browse all 2013 Indian Grand Prix articles (www.f1fanatic.co.uk)
Source: http://feedproxy.google.com/~r/f1fanatic/~3/cYNDvN_sYEM/
Similar Articles: Presidents Cup   The Goldbergs   Nothing Was The Same   danity kane   Deanna Burditt  

U.K. Operator of Madame Tussauds, Legoland Plans IPO



Madame Tussauds London Whitney Houston H



LONDON – Merlin Entertainments, the U.K. operator of such attractions as Madame Tussauds and the London Eye ferris wheel on the river Thames here, is planning an IPO.



The firm is Europe's biggest operator of visitor attractions and is believed to rank second behind Walt Disney worldwide in key metrics.
 
The company runs Madame Tussauds venues in London, Hollywood, New York, Sydney, Tokyo, Shanghai, Hong Kong Amsterdam, Berlin and various other locations. It also operates Alton Towers, Britain's most-visited theme park, Legoland in several European locations, California, Florida and Malaysia, dungeon attractions across the U.K. and Warwick Castle.


The company plans to list its stock in London.


Merlin, currently owned by private equity firms, overall runs 99 attractions in 22 countries. The Guardian said it is believed to be worth as much as $4.8 billion (£3 billion).


The company didn't immediately detail how many shares it would offer and at what price. Merlin plans to use the proceeds from the IPO to pay down debt and invest in its business.


Its revenue for its latest fiscal year topped $1.6 billion (£1 billion).


Alton Towers recently unveiled a deal with BBC Worldwide, the commercial arm of the U.K. public broadcaster, that will lead to the creation of CBeebies Land, an area featuring characters from the BBC's kids channel. The companies said the themed area would include rides, "immersive play areas," live experiences, character appearances and seasonal events.


E-mail: Georg.Szalai@THR.com
Twitter: @georgszalai


Source: http://feedproxy.google.com/~r/thr/business/~3/P2VYLZ0eY1I/story01.htm
Related Topics: Red Sox Schedule   Angela Ahrendts   Teyana Taylor   Nothing Was The Same   Seamus Heaney